These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 10577564)

  • 1. Cytomegalovirus in the pathogenesis of atherosclerosis: the role of inflammation as reflected by elevated C-reactive protein levels.
    Zhu J; Quyyumi AA; Norman JE; Csako G; Epstein SE
    J Am Coll Cardiol; 1999 Nov; 34(6):1738-43. PubMed ID: 10577564
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Host response to cytomegalovirus infection as a determinant of susceptibility to coronary artery disease: sex-based differences in inflammation and type of immune response.
    Zhu J; Shearer GM; Norman JE; Pinto LA; Marincola FM; Prasad A; Waclawiw MA; Csako G; Quyyumi AA; Epstein SE
    Circulation; 2000 Nov; 102(20):2491-6. PubMed ID: 11076822
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytomegalovirus seropositivity and C-reactive protein have independent and combined predictive value for mortality in patients with angiographically demonstrated coronary artery disease.
    Muhlestein JB; Horne BD; Carlquist JF; Madsen TE; Bair TL; Pearson RR; Anderson JL
    Circulation; 2000 Oct; 102(16):1917-23. PubMed ID: 11034939
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Study on the correlation of between infection, inflammation and coronary artery disease].
    Cai XJ; Cai HB; Lu D
    Zhonghua Liu Xing Bing Xue Za Zhi; 2003 Jun; 24(6):503-7. PubMed ID: 12848920
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Are the high levels of cytomegalovirus antibodies a determinant in the development of coronary artery disease?
    Eryol NK; Kiliç H; Gül A; Ozdogru I; Inanç T; Dogan A; Topsakal R; Basar E
    Int Heart J; 2005 Mar; 46(2):205-9. PubMed ID: 15876804
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Statin therapy interacts with cytomegalovirus seropositivity and high C-reactive protein in reducing mortality among patients with angiographically significant coronary disease.
    Horne BD; Muhlestein JB; Carlquist JF; Bair TL; Madsen TE; Hart NI; Anderson JL;
    Circulation; 2003 Jan; 107(2):258-63. PubMed ID: 12538425
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of total pathogen burden on coronary artery disease risk and C-reactive protein levels.
    Zhu J; Quyyumi AA; Norman JE; Csako G; Waclawiw MA; Shearer GM; Epstein SE
    Am J Cardiol; 2000 Jan; 85(2):140-6. PubMed ID: 10955367
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cytomegalovirus infection with interleukin-6 response predicts cardiac mortality in patients with coronary artery disease.
    Blankenberg S; Rupprecht HJ; Bickel C; Espinola-Klein C; Rippin G; Hafner G; Ossendorf M; Steinhagen K; Meyer J
    Circulation; 2001 Jun; 103(24):2915-21. PubMed ID: 11413080
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Concurrent increased high sensitivity C-reactive protein and chronic infections are associated with coronary artery disease: a population-based study.
    Vahdat K; Jafari SM; Pazoki R; Nabipour I
    Indian J Med Sci; 2007 Mar; 61(3):135-43. PubMed ID: 17337814
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of Chlamydia pneumoniae, helicobacter pylori and cytomegalovirus in coronary artery disease.
    Al-Ghamdi A; Jiman-Fatani AA; El-Banna H
    Pak J Pharm Sci; 2011 Apr; 24(2):95-101. PubMed ID: 21454155
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The possible role of hepatitis A virus in the pathogenesis of atherosclerosis.
    Zhu J; Quyyumi AA; Norman JE; Costello R; Csako G; Epstein SE
    J Infect Dis; 2000 Dec; 182(6):1583-7. PubMed ID: 11069227
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chlamydia pneumoniae and cytomegalovirus seropositivity, inflammatory markers, and the risk of myocardial infarction at a young age.
    Gattone M; Iacoviello L; Colombo M; Castelnuovo AD; Soffiantino F; Gramoni A; Picco D; Benedetta M; Giannuzzi P
    Am Heart J; 2001 Oct; 142(4):633-40. PubMed ID: 11579353
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of C-reactive protein, an inflammatory marker, and infectious serology as risk factors for coronary artery disease and myocardial infarction.
    Anderson JL; Carlquist JF; Muhlestein JB; Horne BD; Elmer SP
    J Am Coll Cardiol; 1998 Jul; 32(1):35-41. PubMed ID: 9669246
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic value of interleukin-1 receptor antagonist gene polymorphism and cytomegalovirus seroprevalence in patients with coronary artery disease.
    Rothenbacher D; Brenner H; Mertens T; Hoffmann MM; Hoffmeister A; Koenig W
    BMC Cardiovasc Disord; 2005 May; 5(1):10. PubMed ID: 15943888
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Seropositivity for cytomegalovirus in patients with end-stage renal disease is strongly associated with atherosclerotic disease.
    Betjes MG; Litjens NH; Zietse R
    Nephrol Dial Transplant; 2007 Nov; 22(11):3298-303. PubMed ID: 17597084
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Active cytomegalovirus replication in patients with coronary disease.
    Gredmark S; Jonasson L; Van Gosliga D; Ernerudh J; Söderberg-Nauclér C
    Scand Cardiovasc J; 2007 Aug; 41(4):230-4. PubMed ID: 17680510
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cytomegalovirus infection is associated with elevated interleukin-10 in coronary artery disease.
    Sun Y; Pei W; Welte T; Wu Y; Ye S; Yang Y
    Atherosclerosis; 2005 Mar; 179(1):133-7. PubMed ID: 15721019
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Seropositivity to cytomegalovirus, inflammation, all-cause and cardiovascular disease-related mortality in the United States.
    Simanek AM; Dowd JB; Pawelec G; Melzer D; Dutta A; Aiello AE
    PLoS One; 2011 Feb; 6(2):e16103. PubMed ID: 21379581
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Do associations with C-reactive protein and extent of coronary artery disease account for the increased cardiovascular risk of renal insufficiency?
    Zebrack JS; Anderson JL; Beddhu S; Horne BD; Bair TL; Cheung A; Muhlestein JB;
    J Am Coll Cardiol; 2003 Jul; 42(1):57-63. PubMed ID: 12849660
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Seroprevalence of cytomegalovirus in patients with and without coronary artery diseases at Madani Heart Center, Iran.
    Safaie N; Ghotaslou R; Montazer Ghaem H
    Acta Med Iran; 2010; 48(6):403-6. PubMed ID: 21287482
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.